Is asthma an infectious disease? New evidence

Current Allergy and Asthma Reports

Volumn 13, Issue 6, 2013, Pages 702-709

  Atkinson, T Prescott ^a  

^a Children's of Alabama CPP M220 1601 ^*  (United States)

Author keywords

Antibiotics; Asthma; Chlamydia pneumoniae; Infection; Infectious disease; Microbiome; Mycoplasma pneumoniae; Pathogenesis; Respiratory syncytial virus; Rhinovirus; Viral infections; Virus

Indexed keywords

CLARITHROMYCIN; MACROLIDE; PLACEBO; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; BACTERIAL IMMUNITY; BACTERIAL INFECTION; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFECT; HUMAN; IMMUNE DEFICIENCY; INFECTION; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; PATHOGENESIS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; RHINOVIRUS INFECTION; VIRAL RESPIRATORY TRACT INFECTION; VIRUS IMMUNITY;

ANIMALS; ANTI-BACTERIAL AGENTS; ASTHMA; CHRONIC DISEASE; HUMANS; MICROBIOTA; RESPIRATORY TRACT INFECTIONS;

EID: 84890488913     PISSN: 15297322     EISSN: 15346315     Source Type: Journal    
DOI: 10.1007/s11882-013-0390-8     Document Type: Article

References (92)

1. Lemanske Jr RF. Is asthma an infectious disease?: Thomas A. Neff lecture. Chest. 2003;123:385S-90S.
2. Metz G, Kraft M. Effects of atypical infections with Mycoplasma and Chlamydia on asthma. Immunol Allergy Clin North Am. 2010;30:575-85. vii-viii.
3. Edwards MR, Bartlett NW, Hussell T, Openshaw P, Johnston SL. The microbiology of asthma. Nat Rev Microbiol. 2012;10:459-71.
4. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet. 2006;368:804-13.
5. Borish L, Culp JA. Asthma: a syndrome composed of heterogeneous diseases. Ann Allergy Asthma Immunol. 2008;101:1-8. quiz 8-11, 50.
6. Holgate ST, Lemanske RF, O'Byrne PM, Kakumanu S, Busse WW: Asthma Pathogenesis. In Middleton's Allergy: Principles and Practice, edn 7. Edited by Adkinson NF, Jr., Bochner BS, Busse WW, Holgate ST, Lemanske RF, Simons FER: Elsevier; 2009:893-919. vol 2.]
7. Bisgaard H, Bonnelykke K. Long-term studies of the natural history of asthma in childhood. J Allergy Clin Immunol. 2010;126:187-97. quiz 198-189.
8. Martinez FD. New insights into the natural history of asthma: primary prevention on the horizon. J Allergy Clin Immunol. 2011;128:939-45.
9. Gern JE, Rosenthal LA, Sorkness RL, Lemanske Jr RF. Effects of viral respiratory infections on lung development and childhood asthma. J Allergy Clin Immunol. 2005;115:668-74. quiz 675.
10. Lemanske RF. Viral infections and asthma inception. J Allergy Clin Immunol. 2004;114:1023-6.
11. Cheung DS, Grayson MH. Role of viruses in the development of atopic disease in pediatric patients. Curr Allergy Asthma Rep. 2012;12:613-20.
12. Merrell DS, Falkow S. Frontal and stealth attack strategies in microbial pathogenesis. Nature. 2004;430:250-6.
13. Bonnelykke K, Matheson MC, Pers TH, et al. Meta-analysis of genome-wide association studies identifies ten loci influencing allergic sensitization. Nat Genet. 2013;45:902-6.
14. March ME, Sleiman PM, Hakonarson H. Genetic polymorphisms and associated susceptibility to asthma. Int J Gen Med. 2013;6:253-65.
15. Huang YJ: Asthma microbiome studies and the potential for new therapeutic strategies. Curr Allergy Asthma Rep 2013.
16. Beck JM, Young VB, Huffnagle GB. The microbiome of the lung. Transl Res. 2012;160:258-66.
17. Han MK, Huang YJ, Lipuma JJ, et al. Significance of the microbiome in obstructive lung disease. Thorax. 2012;67:456-63.
18. • Huang YJ, Nelson CE, Brodie EL, et al.: Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J Allergy Clin Immunol 2011, 127:372-381 e371-373. The authors describe the results of analysis of studied the 16S rRNA profile in airway samples from 65 asthmatics and 10 normal controls. They also examine the degree of improvement in bronchial hyperreactivity in patients treated with 16 weeks of clarithromycin as a function of the diversity of their airway microbiome.
19. • Hilty M, Burke C, Pedro H, et al.: Disordered microbial communities in asthmatic airways. PLoS One 2010, 5:8578. In this study the authors cloned and sequenced 16S rRNA sequences from three levels of airway from 5 COPD patients, 11 asthmatics and 8 control subjects to examine the microbiome in chronic lung diseases and healthy individuals.
20. Russell SL, Finlay BB. The impact of gut microbes in allergic diseases. Curr Opin Gastroenterol. 2012;28:563-9.
21. Azad MB, Kozyrskyj AL. Perinatal programming of asthma: the role of gut microbiota. Clin Dev Immunol. 2012;2012:932072.
22. Ly NP, Litonjua A, Gold DR, Celedon JC. Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? J Allergy Clin Immunol. 2011;127:1087-94. quiz 1095-1086.
23. Penders J, Thijs C, van den Brandt PA, et al. Gut microbiota composition and development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut. 2007;56:661-7.
24. Kozyrskyj AL, Ernst P, Becker AB. Increased risk of childhood asthma from antibiotic use in early life. Chest. 2007;131:1753-9.
25. Droste JH, Wieringa MH, Weyler JJ, et al. Does the use of antibiotics in early childhood increase the risk of asthma and allergic disease? Clin Exp Allergy. 2000;30:1547-53.
26. Russell SL, Gold MJ, Willing BP, et al. Perinatal antibiotic treatment affects murine microbiota, immune responses and allergic asthma. Gut Microbes. 2013;4:158-64.
27. Taube C, Muller A. The role of Helicobacter pylori infection in the development of allergic asthma. Expert Rev Respir Med. 2012;6:441-9.
28. Karimi K, Inman MD, Bienenstock J, Forsythe P. Lactobacillus reuteri-induced regulatory T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med. 2009;179:186-93.
29. James KM, Peebles Jr RS, Hartert TV. Response to infections in patients with asthma and atopic disease: an epiphenomenon or reflection of host susceptibility? J Allergy Clin Immunol. 2012;130:343-51.
30. Glezen WP. Asthma, influenza, and vaccination. J Allergy Clin Immunol. 2006;118:1199-206. quiz 1207-1198.
31. Klemets P, Lyytikainen O, Ruutu P, et al. Risk of invasive pneumococcal infections among working age adults with asthma. Thorax. 2010;65:698-702.
32. Talbot TR, Hartert TV, Mitchel E, et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med. 2005;352:2082-90.
33. Juhn YJ, Kita H, Yawn BP, et al. Increased risk of serious pneumococcal disease in patients with asthma. J Allergy Clin Immunol. 2008;122:719-23.
34. Jung JA, Kita H, Dhillon R, et al. Influence of asthma status on serotype-specific pneumococcal antibody levels. Postgrad Med. 2010;122:116-24.
35. Jung JA, Kita H, Yawn BP, et al. Increased risk of serious pneumococcal disease in patients with atopic conditions other than asthma. J Allergy Clin Immunol. 2010;125:217-21.
36. ACIP-Pneumococcal-Vaccines-Working-Group. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine. MMWR Morb Mortal Wkly Rep. 2010;59:1-19.
37. ACIP-Pneumococcal-Vaccines-Working-Group. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep. 2010;59:1102-6.
38. Capili CR, Hettinger A, Rigelman-Hedberg N, et al. Increased risk of pertussis in patients with asthma. J Allergy Clin Immunol. 2012;129:957-63.
39. Stein RT. Long-term airway morbidity following viral LRTI in early infancy: recurrent wheezing or asthma? Paediatr Respir Rev. 2009;10 Suppl 1:29-31.
40. Jackson DJ, Lemanske Jr RF. The role of respiratory virus infections in childhood asthma inception. Immunol Allergy Clin North Am. 2010;30:513-522, vi.
41. Wu P, Hartert TV. Evidence for a causal relationship between respiratory syncytial virus infection and asthma. Expert Rev Anti Infect Ther. 2011;9:731-45.
42. Jartti T, Korppi M. Rhinovirus-induced bronchiolitis and asthma development. Pediatr Allergy Immunol. 2011;22:350-5.
43. Gavala ML, Bertics PJ, Gern JE. Rhinoviruses, allergic inflammation, and asthma. Immunol Rev. 2011;242:69-90.
44. Lotz MT, Peebles Jr RS. Mechanisms of respiratory syncytial virus modulation of airway immune responses. Curr Allergy Asthma Rep. 2012;12:380-7.
45. Sly PD, Kusel M, Holt PG. Do early-life viral infections cause asthma? J Allergy Clin Immunol. 2010;125:1202-5.
46. Simoes EA, Carbonell-Estrany X, Rieger CH, et al. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol. 2010;126:256-62.
47. Papadopoulos NG, Christodoulou I, Rohde G, et al. Viruses and bacteria in acute asthma exacerbations-a GA(2) LEN-DARE systematic review. Allergy. 2011;66:458-68.
48. Busse WW, Lemanske Jr RF, Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet. 2010;376:826-34.
49. Sears MR. Epidemiology of asthma exacerbations. J Allergy Clin Immunol. 2008;122:662-8. quiz 669-670.
50. Khetsuriani N, Kazerouni NN, Erdman DD, et al. Prevalence of viral respiratory tract infections in children with asthma. J Allergy Clin Immunol. 2007;119:314-21.
51. Holt PG, Strickland DH, Sly PD. Virus infection and allergy in the development of asthma: what is the connection? Curr Opin Allergy Clin Immunol. 2012;12:151-7.
52. Gern JE. The ABCs of rhinoviruses, wheezing, and asthma. J Virol. 2010;84:7418-26.
53. Calhoun WJ, Swenson CA, Dick EC, et al. Experimental rhinovirus 16 infection potentiates histamine release after antigen bronchoprovocation in allergic subjects. Am Rev Respir Dis. 1991;144:1267-73.
54. Lemanske Jr RF, Dick EC, Swenson CA, et al. Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest. 1989;83:1-10.
55. Gern JE, Busse WW. The effects of rhinovirus infections on allergic airway responses. Am J Resp Crit Care Med. 1995;152:S40-5.
56. • Caliskan M, Bochkov YA, Kreiner-Moller E, et al.: Rhinovirus wheezing illness and genetic risk of childhood-onset asthma. N Engl J Med 2013, 368:1398-1407. The authors examined two large multicenter studies in children for risk of recurrent wheezing following viral infection in relation to polymorphisms at known genetic loci associated with asthma. They found that HRV but not RSV infection was associated with the development of wheezing in subjects bearing a chromosome 17q21 variant and with the expression level of two genes at that locus.
57. Eaton MD, Meiklejohn G, van Herick W. Studies on the etiology of primary atypical pneumonia. A filterable agent transmissible to cotton rats, hamsters, and chicken embryos. J Exp Med. 1944;79:649-68.
58. Atmar RL, Greenberg SB. Pneumonia caused by Mycoplasma pneumoniae and the TWAR agent. Semin Respir Infect. 1989;4:19-31.
59. Yavlovich A, Tarshis M, Rottem S. Internalization and intracellular survival of Mycoplasma pneumoniae by non-phagocytic cells. FEMS Microbiol Lett. 2004;233:241-6.
60. Meseguer MA, Alvarez A, Rejas MT, et al. Mycoplasma pneumoniae: a reduced-genome intracellular bacterial pathogen. Infect Genet Evol. 2003;3:47-55.
61. Dallo SF, Baseman JB. Intracellular DNA replication and long-term survival of pathogenic Mycoplasmas. Microb Pathog. 2000;29:301-9.
62. Specjalski K, Jassem E. Chlamydophila pneumoniae, Mycoplasma pneumoniae infections, and asthma control. Allergy Asthma Proc. 2011;32:9-17.
63. Good Jr JT, Rollins DR, Martin RJ. Macrolides in the treatment of asthma. Curr Opin Pulm Med. 2012;18:76-84.
64. Sutherland ER, Martin RJ. Asthma and atypical bacterial infection. Chest. 2007;132:1962-6.
65. Roulis E, Polkinghorne A, Timms P. Chlamydia pneumoniae: modern insights into an ancient pathogen. Trends Microbiol. 2013;21:120-8.
66. Peeling RW, Brunham RC. Chlamydiae as pathogens: new species and new issues. Emerg Infect Dis. 1996;2:307-19.
67. Smieja M, Mahony J, Petrich A, et al. Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review. BMC Infect Dis. 2002;2:21.
68. Hammerschlag MR. Chlamydia pneumoniae and asthma in children: diagnostic issues. Clin Infect Dis. 2004;39:1251-2. author reply 1252-1253.
69. Boman J, Gaydos CA. Polymerase chain reaction detection of Chlamydia pneumoniae in circulating white blood cells. J Infect Dis. 2000;181 Suppl 3:S452-4.
70. Apfalter P, Hammerschlag MR, Boman J. Reliability of nested PCR for the detection of Chlamydia pneumoniae in carotid artery atherosclerosis. Stroke. 2003;34:e73-5. author reply e73-75.
71. Poritz MA, Blaschke AJ, Byington CL, et al. FilmArray, an automated nested multiplex PCR system for multi-pathogen detection: development and application to respiratory tract infection. PLoS One. 2011;6:e26047.
72. Smith-Norowitz TA, Silverberg JI, Kusonruksa M, et al. Asthmatic children have increased specific anti-Mycoplasma pneumoniae IgM but not IgG or IgE-values independent of history of respiratory tract infection. Pediatr Infect Dis J. 2013;32:599-603.
73. Atkinson TP, Duffy LB, Pendley D, et al. Deficient immune response to Mycoplasma pneumoniae in childhood asthma. Allergy Asthma Proc. 2009;30:158-65.
74. Biberfeld G, Sterner G. A study of Mycoplasma pneumoniae infections in families. Scand J Infect Dis. 1969;1:39-46.
75. • Peters J, Singh H, Brooks EG, et al.: Persistence of CARDS toxin-producing Mycoplasma pneumoniae in refractory asthma. Chest 2011 140(2):401-7. The authors use new, highly sensitive PCR and antigen-capture assays for the CARDS toxin gene and protein, respectively, to demonstrate that subjects with refractory asthma have a high prevalence of positivity (approximately 50%) for Mpn. Although intriguing, this study lacks normal control subjects.
76. Martin RJ, Kraft M, Chu HW, et al. A link between chronic asthma and chronic infection. J Allergy Clin Immunol. 2001;107:595-601.
77. Waites KB. What's new in diagnostic testing and treatment approaches for Mycoplasma pneumoniae infections in children? Adv Exp Med Biol. 2011;719:47-57.
78. Sabato AR, Martin AJ, Marmion BP, et al. Mycoplasma pneumoniae: acute illness, antibiotics, and subsequent pulmonary function. Arch Dis Child. 1984;59:1034-7.
79. Wongtim S, Mogmued S. Methacholine inhalation challenge in patients with post-Mycoplasma pneumoniae pneumonia. Asian Pac J Allergy Immunol. 1995;13:5-10.
80. Marc E, Chaussain M, Moulin F, et al. Reduced lung diffusion capacity after Mycoplasma pneumoniae pneumonia. Pediatr Infect Dis J. 2000;19:706-10.
81. Kjaer BB, Jensen JS, Nielsen KG, et al. Lung function and bronchial responsiveness after Mycoplasma pneumoniae infection in early childhood. Pediatr Pulmonol. 2008;43:567-75.
82. • Sutherland ER, King TS, Icitovic N, et al.: A trial of clarithromycin for the treatment of suboptimally controlled asthma. J Allergy Clin Immunol 2010, 126:747-753. In this study, while failing to achieve the power needed to test the effect of clarithromycin as an attempt to repeat the work of Kraft, et al. [91], the authors yet found that 12% of chronic stable adult asthmatics were positive for Mpn. Samples from this study were also used the microbiome studies by Huang, et al. [18•].
83. Sasaki A, Ouchi K, Makata H, et al. The effect of inhaled corticosteroids on Chlamydophila pneumoniae and Mycoplasma pneumoniae infection in children with bronchial asthma. J Infect Chemother. 2009;15:99-103.
84. Chu HW, Campbell JA, Rino JG, et al. Inhaled fluticasone propionate reduces concentration of Mycoplasma pneumoniae, inflammation, and bronchial hyperresponsiveness in lungs of mice. J Infect Dis. 2004;189:1119-27.
85. Wood PR, Hill VL, Burks ML, et al. Mycoplasma pneumoniae in children with acute and refractory asthma. Ann Allergy Asthma Immunol. 2013;110:328-34. e321.
86. Kannan TR, Baseman JB. ADP-ribosylating and vacuolating cytotoxin of Mycoplasma pneumoniae represents unique virulence determinant among bacterial pathogens. Proc Natl Acad Sci U S A. 2006;103:6724-9.
87. Medina JL, Coalson JJ, Brooks EG, et al. Mycoplasma pneumoniae CARDS toxin induces pulmonary eosinophilic and lymphocytic inflammation. Am J Respir Cell Mol Biol. 2012;46:815-22.
88. Hardy RD, Coalson JJ, Peters J, et al. Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin. PLoS One. 2009;4:e7562.
89. Griffin MO, Ceballos G, Villarreal FJ. Tetracycline compounds with non-antimicrobial organ protective properties: possible mechanisms of action. Pharmacol Res. 2011;63:102-7.
90. Reiter J, Demirel N, Mendy A, et al. Macrolides for the long-term management of asthma: A meta-analysis of randomized clinical trials. Allergy. 2013;68:1040-9.
91. Kraft M, Cassell GH, Pak J, Martin RJ. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: Effect of clarithromycin. Chest. 2002;121:1782-8.
92. Daoud A, Gloria CJ, Taningco G, et al. Minocycline treatment results in reduced oral steroid requirements in adult asthma. Allergy Asthma Proc. 2008;29:286-94.